Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Series/ Type

Series/type

Search tool

Displaying 1 - 20 of 77

Publications

Final EMCDDA annual accounts for the financial year 2021

04.07.2022

These accounts have been drawn up and signed off by the Accounting Officer on 23 May 2022 and approved by the Director on 24 May 2022. The opinion of the Management Board was given favourably on 21 June 2022. The present annual accounts, together with the opinion of the Management Board, have been...

Publications

A foresight toolkit for the drugs field

30.06.2022

This toolkit aims to support the EMCDDA’s stakeholders, other actors and researchers in the drugs field to implement their own foresight exercise in the form of an introductory trend-based workshop. It describes briefly the foresight and trend analysis approach and general principles of how both...

Publications

How to run a trends workshop: An EMCDDA foresight toolkit for the drugs field

24.06.2022

This toolkit aims to support the EMCDDA’s stakeholders, other actors and researchers in the drugs field to implement their own foresight exercise in the form of an introductory trend-based workshop. It describes briefly the foresight and trend analysis approach and general principles of how both...

Publications

General Report of Activities 2021 – key achievements and governance: a year in review

15.06.2022

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking...

Publications

Timeline: 25 years of Early Warning System (EWS)

06.06.2022

Take a journey through some of the key events over the last 25 years of monitoring new psychoactive substances in Europe.

Publications

Risk assessment of new psychoactive substances (NPS)

18.03.2022

Risk assessment is the second step in the three-step legal framework designed to allow the European Union (EU) to rapidly detect, assess, and respond to health and social threats caused by new psychoactive substances (NPS). On this page you can learn the role of the risk assessment in the EU earl...

Publications

Single programming document 2022–2024

27.01.2022

This single programming document (SPD) covers the period 2022–2024. It is presented in line with the guidelines of the European Commission for a single programming document and the consolidated annual activity report of decentralised agencies. Within this template, the substantive work is...

Publications

EMCDDA corporate identity and logo toolkit

24.09.2021

This toolbox provides guidelines and downloadable resources related to the EMCDDA logo.

Publications

Final EMCDDA annual accounts for the financial year 2020

08.07.2021

These accounts have been drawn up and signed off by the Accounting Officer on 31 May 2021 and approved by the Director on 1 June 2021. The opinion of the Management Board was given favourably on 24 June 2021. The present annual accounts, together with the opinion of the Management Board, have been...

Publications

General Report of Activities 2020 – key achievements and governance: a year in review

15.06.2021

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking...

Publications

European Drug Report 2021: Trends and Developments

09.06.2021

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm reduction interventions.

Publications

Reitox Development Framework - Roadmap 2025

16.05.2021

During the year 2021 new roadmaps were defined for the agency’s Strategy 2025 and for its accompanying document, the Reitox Development Framework (RDF). These two roadmaps describe the activities and milestones to be implemented to reach the strategic and specific objectives set out in the longer-...

Publications

Reitox Development Framework Roadmap 2020 - Evaluation of the implementation

16.05.2021

In 2017, when the Reitox Development Framework (RDF) was prepared and adopted, one of the key issues underlined by the Centre and the network alike was the need to ensure its execution through the definition of concrete implementing activities; and that the implementation of those activities would...

Publications

Single programming document 2021–2023

12.02.2021

The new Single programming document sets out the EMCDDA’s activities for the period 2021–2023, marking the start of a new five-year roadmap under Strategy 2025. At the heart of the agency’s work in 2021 will be the development of a new business model, which places customers and digital...

Publications

EMCDDA certification of the Reitox national focal points

15.12.2020

This document describes the EMCDDA's Reitox certification process. The Reitox certification project is a process for formal acknowledgement of the competence of an EMCDDA national focal point to carry out specific tasks in a reliable, credible and accurate manner and confirmation that it meets the...

Publications

Protocol for updating the Evidence database of the Best Practice Portal

14.12.2020

The Evidence database is a core component of the EMCDDA’s Best Practice Portal. The portal is a resource for professionals, policymakers and researchers in the drugs field and provides information on the available evidence on drug-related prevention, treatment and harm reduction, focusing on the...

Publications

Reitox national focal points’ activities during the COVID-19 pandemic

11.12.2020

This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to overcome these challenges.

Publications

Looking back on 25 years of annual reporting on the drugs problem in Europe

29.09.2020

In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe. The journey begins with the first report describing the drug situation in 1995 and leads us, over key milestones, to the latest European Drug Report 2020....

Publications

Annual accounts 2019

07.07.2020

These are the EMCDDA's final annual accounts for the financial year 2019.

Publications

General Report of Activities 2019 – key achievements and governance: a year in review

15.06.2020

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking...
Loading